Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T16:37:30.554Z.
Calculation as of: 2026-10-06T16:37:30.554Z.
Quote observation: 2026-10-06T16:34:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4b900084dfad819c514917b73a3910c9d2e92354b8183d11bfa5ab73513aed11
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
SeaStar Medical Holding Corporation
Market Cap
$9.37M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.33M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.57M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.06M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.45M
Price/FCF Ratio
N/A
TTM Avg
9.96
3Y Avg
9.96
5Y Avg
9.96
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SeaStar Medical Holding Corporation (ICU) | $9.37M | N/A | N/A | N/A | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.33M | N/A | N/A | N/A | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.17M | N/A | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.57M | N/A | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $9.68M | N/A | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.72M | N/A | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $9.92M | N/A | N/A | N/A | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | N/A | N/A | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.45M | N/A | 9.96 | 9.96 | 9.96 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.38M | N/A | 5.33 | 5.33 | 5.33 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
